Related Experiment Video

Updated: Aug 23, 2026

Isolation of Chondrocytes and Chondroprogenitors Using Fibronectin Adhesion and Migratory Assay
08:09

Isolation of Chondrocytes and Chondroprogenitors Using Fibronectin Adhesion and Migratory Assay

Published on: October 4, 2024

RNAi of COL1A1 in mesenchymal progenitor cells

Sophia Millington-Ward1, Helena P McMahon, Danny Allen

  • 1Ocular Genetics Unit, Department of Genetics, Trinity College Dublin, Dublin 2, Ireland. sophia@maths.tcd.ie

European Journal of Human Genetics : EJHG
|July 9, 2004
PubMed

Insights

RNA interference effectively reduces COL1A1 gene expression in bone progenitor cells. This approach shows promise for treating Osteogenesis Imperfecta by targeting specific gene variants, offering a potential mutation-independent therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Regenerative Medicine

Background:

  • Mutations in the COL1A1 gene are a primary cause of Osteogenesis Imperfecta (OI).
  • Developing effective therapies for OI requires precise modulation of COL1A1 expression.
  • RNA interference (RNAi) presents a potential strategy for gene silencing.

Purpose of the Study:

  • To assess the efficacy of RNA interference (RNAi) in downregulating COL1A1 expression.
  • To investigate RNAi's potential as a therapeutic tool for Osteogenesis Imperfecta (OI).
  • To explore allele-specific RNAi for a mutation-independent OI therapy targeting COL1A1 intragenic SNPs.

Main Methods:

  • RNA interference (RNAi) was employed to target COL1A1 expression.
  • Experiments were conducted in Cos-7 cells and human mesenchymal progenitor stem cells (MPCs).
  • Allele-specific suppression was evaluated by targeting single nucleotide polymorphisms (SNPs) within COL1A1 transcripts.

Main Results:

  • RNAi successfully downregulated COL1A1 expression in both cell types.
  • Preferential suppression of specific polymorphic alleles differing by a single nucleotide was observed.
  • Demonstrated allele-specific silencing of COL1A1 transcripts.

Conclusions:

  • RNA interference is a viable method for reducing COL1A1 expression in relevant cell types.
  • Targeting intragenic SNPs with RNAi offers a promising avenue for mutation-independent Osteogenesis Imperfecta therapies.
  • Allele-specific RNAi demonstrates potential for precise genetic modulation in collagen-related disorders.

More Related Videos

Co-localization of Cell Lineage Markers and the Tomato Signal10:56

Co-localization of Cell Lineage Markers and the Tomato Signal

Published on: December 28, 2016

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...